The De-Morton Mobility Index Turkish Version in Intensive Care Patients

January 9, 2022 updated by: Ilknur Naz, Izmir Katip Celebi University

Construct Validity and Test-Retest Reliability of The De-Morton Mobility Index Turkish Version in Intensive Care Patients

De Morton Mobility Index is recommended for the evaluation of mobility in the evidence-based guidelines, in patients in intensive care units. The aim of our study is to examine the validity and reliability of the Turkish version of the De Morton Mobility Index in patients hospitalized in the respiratory intensive care unit.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

De Morton Mobility Index is recommended for the evaluation of mobility in the evidence-based guidelines, in patients in intensive care units. The aim of our study is to examine the validity and reliability of the Turkish version of the De Morton Mobility Index in patients hospitalized in the respiratory intensive care unit.

Patients aged 18 years and over who were discharged from the ICU were included in our study.

We used De-Morton Mobility Index, Bartel Index, Katz Activities of Daily Living Rating Scale and MRC Muscle Strength Test for convergent validity. De-Morton Mobility assessment for test-retest reliability was performed again on the 1st day of the patient's service.

Study Type

Observational

Enrollment (Actual)

150

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • İzmir, Turkey, 35620
        • İlknur Naz Gürşan

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients aged above 18 years who stayed in the intensive care unit for at least 24 hours and were discharged from the ICU were included in our study.

Description

Inclusion Criteria:

  • staying in intensive care unit for at least 24 hours
  • able to cooperate
  • being clinically stable for mobility assessment

Exclusion Criteria:

  • the presence of neurological disease
  • the presence of orthopedic problems such as fractures
  • the presence of metastases
  • the presence of cardiorespiratory instability

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Cross-Sectional

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mobility Assessment
Time Frame: 15 minutes
De Morton Mobility Index: It consists of a total of 15 mobility items. The total score ranges from 0-100, with 0 indicating poor mobility and 100 indicating high mobility
15 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional independence measurement
Time Frame: 5 minutes
The Barthel index: It includes 10 items: nutrition, bathroom, personal care, dressing, toilet use, mobility on flat surfaces (immobile, wheelchair use, walking with assistance or independently), transfer (transfer from wheelchair to bed and vice versa), climbing stairs, bowel and bladder continence. It is scored between 0-100. 0; fully independent, 100; means fully independent.
5 minutes
Assessment of daily living activities
Time Frame: 5 minutes
Katz Index: The index includes basic parameters of daily living activities such as bathing, dressing, toilet, transfer, urine and stool control, nutrition. The scoring of the index varies in the range of 0-6. Higher scores indicate higher independence
5 minutes
Muscle Strength
Time Frame: 10 minutes
Medical Research Council scale: It includes muscle strength test of six muscle groups. Scoring ranges from 0 to 5 in each muscle group. The maximum score is 60, and a score below 48 indicates significant muscle weakness
10 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Izmir Katip Celebi University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2018

Primary Completion (Actual)

February 20, 2019

Study Completion (Actual)

February 20, 2019

Study Registration Dates

First Submitted

January 9, 2022

First Submitted That Met QC Criteria

January 9, 2022

First Posted (Actual)

January 19, 2022

Study Record Updates

Last Update Posted (Actual)

January 19, 2022

Last Update Submitted That Met QC Criteria

January 9, 2022

Last Verified

January 1, 2022

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • DM111

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Critical Care

Clinical Trials on Mobility and Functional Assessments

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Israel

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe